
Subscribe to all:
Novo Nordisk Raised to `Buy' at Goldman Sachs
July 1 (Bloomberg) -- Novo Nordisk A/S, was raised to
``buy'' from ``neutral'' at Goldman Sachs Group Inc. Analysts'
calls for additional stocks include EXCO Resources Inc., Myriad
Genetics Inc. and NovaMed Inc.
Use of Bloomberg Podcast content is subject to the www.bloomberg.com
Terms of Service. Bloomberg is not responsible for the content of third party sites or any third party software applications.